View More Recent Stories

Feb 21, 2017 08:00AM Veracyte Announces Ten New Blues Plan Coverage Policies for Its Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis
Feb 15, 2017 08:00AM Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2016 Financial Results on Wednesday, March 1, 2017
Feb 8, 2017 08:05AM Veracyte (VCYT) Enters Agreement with Quest Diagnostics (DGX) to Expand Patient Access to GEC
Feb 8, 2017 08:00AM Veracyte to Expand Patient Access to the Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement with Quest Diagnostics
Feb 6, 2017 08:08AM Veracyte (VCYT) Announces Final Medicare Coverage Policies for Percepta
Feb 6, 2017 08:00AM Veracyte Announces Final Medicare Coverage Policies for Percepta® Bronchial Genomic Classifier
Feb 2, 2017 08:00AM Veracyte to Present at LEERINK Partners 6th Annual Global Healthcare Conference
View More Recent Stories